Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.34B | 2.10B | 1.89B | 1.88B | 2.05B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.34B | 2.10B | 1.89B | 1.88B | 2.05B |
| Cost of Revenue | 1.99B | 1.74B | 1.51B | 1.48B | 1.68B |
| Gross Profit | 350.28M | 361.64M | 381.19M | 399.88M | 378.34M |
| SG&A Expenses | 271.17M | 277.70M | 284.13M | 288.47M | 273.60M |
| Depreciation & Amortization | 109.65M | 111.77M | 113.35M | 115.85M | 78.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.37B | 2.12B | 1.91B | 1.88B | 2.03B |
| Operating Income | -30.53M | -27.84M | -16.29M | -4.44M | 26.24M |
| Income Before Tax | -504.63M | -502.14M | -497.21M | -534.64M | -127.75M |
| Income Tax Expenses | 3.07M | 2.85M | -686.00K | -126.00K | 430.00K |
| Earnings from Continuing Operations | -507.69 | -504.99 | -496.52 | -534.51 | -128.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -507.69M | -504.99M | -496.52M | -534.51M | -128.18M |
| EBIT | -30.53M | -27.84M | -16.29M | -4.44M | 26.24M |
| EBITDA | 56.02M | 61.04M | 74.36M | 88.22M | 80.95M |
| EPS Basic | -4.54 | -4.57 | -4.76 | -5.15 | -1.57 |
| Normalized Basic EPS | -0.54 | -0.52 | -0.42 | -0.60 | -0.36 |
| EPS Diluted | -4.54 | -4.57 | -4.76 | -5.15 | -1.57 |
| Normalized Diluted EPS | -0.54 | -0.52 | -0.42 | -0.60 | -0.36 |
| Average Basic Shares Outstanding | 449.13M | 450.13M | 453.47M | 456.88M | 460.30M |
| Average Diluted Shares Outstanding | 449.13M | 450.13M | 453.47M | 456.88M | 460.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -0.38% | -1.32% | -2.08% | -12.43% |